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Abstract - Alpha-bisabolol, an anti-inflammatory and antioxidant compound extracted from candeia trees 
(Eremanthus erythropappus), was incorporated into hydrophobic polycaprolactone (PCL) and hydrophilic 
chitosan/guar gum (Ch-G) membranes aiming at the production of bioactive wound dressings. The 
incorporation efficiency achieved a maximum of ca. 18% (1 gram of alpha-bisabolol per gram of membrane) 
for Ch-G membranes. For PCL membranes, all of the active compound added was retained (0.2 gram of 
alpha-bisabolol per gram of membrane). Alpha-bisabolol release in phosphate-buffered saline was relatively 
slow in both cases, reaching around 6% and 24% after 120 hours respectively for PCL and Ch-G membranes 
presenting equivalent initial alpha-bisabolol/membrane mass ratios. Both formulations were capable of 
releasing alpha-bisabolol in the typically recommended topical dose range (from 1 to 10 grams of alpha-
bisabolol per gram of vehicle). The extended release periods observed are advantageous, allowing less 
frequent dressing changes and contributing to turn the treatment more comfortable for the patient.  
Keywords: Wound dressing; Membrane; Chitosan; Guar gum; Polycaprolactone; Alpha-bisabolol. 
 
 
 
INTRODUCTION 
 
The skin is the largest organ of the human body 
and acts as an interface with the external environ-
ment. This organ presents a complex structure and 
exerts functions that are crucial for life, such as 
thermoregulation, immune surveillance, sensitivity 
and mechanical barrier (Tortora and Derrickson, 
2012). Skin lesions may affect this organ at different 
depths, reaching one or more of its layers and im-
pairing its functions (Hess, 2005).  
Wound dressings can be used to aid and enhance 
the natural healing process of an injury (Franco and 
Gonçalves, 2008), and the development of dressings 
with specific properties to treat different types of 
lesions has advanced significantly in the last dec-
ades. Wound dressings are used to protect the lesion 
from mechanical damage and contamination by mi-
croorganisms, as well as to provide an appropriate 
environment for the healing process, which includes 
the restoration of the epithelium and the formation of 
collagen (Weller and Sussman, 2006; Mulder et al., 
2002). They can be classified according to the role 
they play in the lesion (barrier, debridement, anti-
bacterial, occlusive, absorbent, adherent), the type of 
material used in its production (hydrocolloid, algi-
nate, collagen, etc.) and also their physical form (oint-
ment, film, foam, gel) (Boateng et al., 2008). An-
other classification refers to the form of interaction 
between the dressing and the lesion. According to 
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this classification, the materials used as wound dress-
ings are divided into inert or passive, interactive and 
bioactive (Agrawal et al., 2014). Bioactive dressings 
are capable of interacting with the injured tissue, 
helping to reduce or eliminate pain and inflammatory 
processes, stimulating and accelerating the healing 
process (Weller and Sussman, 2006). 
Several types of synthetic and natural polymers 
may be used for the production of dressings (Sezer 
and Cevher, 2011). Polymers of natural origin, or bio-
polymers, can be extracted from different sources, 
such as vegetables, animals or seaweeds or produced 
from fermentative pathways and enzymatic pro-
cesses. Frequently biopolymers have higher biocom-
patibility and lower immunogenicity when compared 
to those of synthetic origin for the use in medical 
applications (Bhardwaj and Kundu, 2010). Natural 
polymers can mimic many of the characteristics of 
the extracellular matrix, therefore being able to direct 
the migration, growth, and organization of cells 
during the process of regeneration and healing of 
damaged tissue (Huang and Fu, 2010). The degrada-
tion of these polymers depends on enzymatic 
processes and also on the type of biopolymer used, 
thus the degradation rate can vary from patient to 
patient (Cheung et al., 2007). Synthetic polymers, on 
the other hand, are advantageous in comparison to 
biopolymers because they are more flexible and 
more easily processed to meet different application 
requirements. The ability to manipulate the proper-
ties of synthetic polymers allows obtaining materials 
with uniform characteristics and low lot-to-lot varia-
tion (Middleton and Tipton, 2000). These polymers 
are readily adaptable to exert a wide range of func-
tional properties and it is possible to manipulate, for 
example, their molar mass, mechanical properties 
and degradability (Bhardwaj and Kundu, 2010). In 
the case of synthetic polymers, the degradability is 
related to hydrolysis (mostly of ester bonds), and 
thus the degradation rate does not vary from patient 
to patient, except for the occurrence of local inflam-
mation, which may cause pH variations (Cheung et 
al., 2007). Chitosan and guar gum, polymers of 
natural origin, and polycaprolactone, a polymer of 
synthetic origin, are examples of materials widely used 
in the medical field. 
Chitosan is a linear semi-crystalline polysaccha-
ride with molecular weight ranging from 300 to 1000 
kDa (Rinaudo, 2006; Liu et al., 2011). Its chemical 
structure is composed of a copolymer formed by 
units of N-acetyl-D-glucosamine (2-acetamido-2-
deoxy-D-glucan) and D-glucosamine (2-amino-2-
deoxy-D-glucan) joined by glycosidic β (1-4) link-
ages (Goycoolea et al., 2000). Chitosan is not com-
monly found in nature but can be readily obtained 
from chitin, a natural polymer mainly extracted from 
the exoskeleton of crustaceans, through deacetylation 
(Goycoolea et al., 2000). It is a biocompatible, bio-
degradable and bioadhesive polymer, slightly soluble 
in acidic solutions and with many important biologi-
cal properties such as antifungal, antibacterial and 
haemostatic effect in certain conditions of use (Ber-
ger et al., 2004; Paul and Sharma, 2004). In addition, 
this polymer stimulates macrophage function, which 
accelerates the healing process of injuries (Paul and 
Sharma, 2004). Chitosan degradation occurs in the 
body through the action of enzymes, in particular, 
lysozyme present in human body fluids, leading to 
the formation of non-toxic oligosaccharides that are 
incorporated into metabolic routes and naturally elimi-
nated from the organism (Kumar, 2000; Croisier and 
Jérôme, 2013). 
Guar gum is a neutral water-soluble polysaccha-
ride, extracted from the seeds of the plant Cyamopsis 
tetragonolobus (Prabhanjan et al., 1989), with mean 
molar mass varying from 50 to 8000 kDa (Kawa-
mura, 2008). Its molecular structure consists of a 
linear chain of D-mannopyranose residues to which a 
D-galactopyranose residue is linked, on average, to 
every alternate mannose (Prabhanjan et al., 1989; 
Coviello et al., 2007). Guar gum is biodegraded if in-
gested, and its degradation occurs in the human 
colon by enzymes such as alpha-galactosidase and 
beta-mannanase, which are produced by colonic bac-
teria (Gliko-Kabir et al., 2000). This biopolymer is 
employed in various pharmaceutical formulations, 
including capsules, hydrogels, films and nano- or 
micro-particles and has been explored as a potential 
matrix for drug delivery systems (Prabaharan, 2011). 
It is also used in combination with carboxymethyl-
cellulose as hydrocolloid dressings applicable to par-
tial and full-thickness wounds with low to moderate 
exudation. However, given that even after a week of 
use the formation of only limited degradation resi-
dues is observed, this type of biomaterial is not 
recommended for very deep lesions with tunneling 
(Bower et al., 2011). Guar gum can be associated 
with chitosan to form a physical complex and the 
synergy between the two biopolymers has been 
studied and applied in the development of different 
medical devices (Haupt et al., 2006; Randhawa et 
al., 2012). 
Polycaprolactone is a biodegradable synthetic poly-
mer obtained from the polymerization of epsilon-
caprolactone. It is a linear aliphatic polyester, semi-
crystalline and hydrophobic (Pitt, 1990), with average 
molecular weight generally ranging from 3 to 80 kDa 
(Woodruff and Hutmacher, 2010). PCL degradation 
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occurs in two steps: first, by nonenzymatic hydrolysis 
of ester groups and second, intracellular degradation 
by macrophage and phagosomes. Since its molar mass 
can be reduced to 3 kDa or less during the degradation 
process, as a consequence, PCL is completely ab-
sorbed in vivo in due time (Woodward et al., 1985). 
Its excellent biocompatibility and ability to be ab-
sorbed by the body together with its high permeabil-
ity to many drugs and bioactive compounds make it 
suitable for the development of non-removable con-
trolled release devices (Woodruff and Hutmacher, 
2010). 
Many of the materials used as dressings have in-
trinsic biological activity themselves and may be 
formulated to also act as controlled release systems 
of bioactive compounds incorporated in them. Con-
trolled release in specific body areas is important as 
it minimizes loss and degradation of the active com-
pound and increases its availability in the treated 
region (Boateng et al., 2008). 
Bioactive compounds of natural and synthetic 
origin are likely to be incorporated into wound dress-
ings. Such compounds include antimicrobial agents, 
compounds with anti-inflammatory activity, growth 
factors and vitamins, among others (Boateng et al., 
2008). Plants produce a wide variety of phytochemi-
cals, which have been used by humans for centuries 
to treat different kinds of diseases. Due to the wide-
spread development and production of well-charac-
terized synthetic bioactive agents, the use of natural 
products has been left aside for many years (Cragg 
and Newman, 2013; Newman and Cragg, 2007; Patra, 
2012). However, the development of resistance in 
various bacterial strains to synthetic antibiotics and 
antimicrobial agents, as well as concerns regarding 
their efficacy and safety revived interest in the use of 
natural compounds as alternatives to synthetic ones 
(Patra, 2012).  
An example of a natural compound useful in the 
treatment of skin lesions is alpha-bisabolol, a mono-
cyclic unsaturated sesquiterpene alcohol found in 
plant species such as Matricaria chamomilla, Matri-
caria recutita, Salvia runcinata, Salvia stenophylla, 
Vanillosmopsis pohlii, Vanillosmopsis arborea, My-
oporum grassifolium and Eremanthus erythropap-
pus. Its content in these species varies from 50% to 
90% (Kamatou and Viljoen, 2010). In Brazil, alpha-
(-)-bisabolol is mainly extracted from the bark of 
candeia trees (Eremanthus erythropappus), reaching 
purity levels equal to or above 95% after processing 
(Clark et al., 2011). This compound has a wide range 
of relevant biological properties, such as antimicro-
bial, antifungal, antispasmodic, analgesic, antioxi-
dant and anti-inflammatory effects. It is commonly 
used in topical formulations in dosages from 0.1 to 
1% (1 to 10 mg per gram of vehicle) (Kamatou and 
Viljoen, 2010; Petronilho et al., 2012). 
Alpha-bisabolol is a lipophilic compound, practi-
cally insoluble in water but soluble in ethanol (Ka-
matou and Viljoen, 2010). It has a molar weight of 
222.37 g/mol, density of about 0.93 g/mL and boil-
ing point of 314.5 °C at 1 atm. This compound exists 
in the form of four diastereoisomers (Figure 1). The 
most common form is alpha-(-)-bisabolol or levome-
nol, which is primarily responsible for the overall bio-
logical activity of the compound, while the isomer 
alpha-(+)-bisabolol is rare in nature. The synthetic 
compound is usually a mixture of alpha-(±)-bisabo-
lol, containing at least 42.5% of alpha-(-)-bisabolol 
(Kamatou and Viljoen, 2010; Schilcher et al., 2005, 
Clark et al., 2011). 
So far, no detailed reports were found in the liter-
ature regarding the incorporation of alpha-bisabolol 
either in hydrophilic or in hydrophobic membranes 
constituted, respectively, of chitosan combined with 
guar gum and of polycaprolactone. Hence, the aim of 
this work was to examine the incorporation of alpha-
bisabolol in such matrices and its effects on mem-
brane properties, with a focus on their application as 
controlled release devices for the therapy of skin le-
sions. Characteristics such as differences in mem-
brane morphology, color, opacity, Fourier transform 
infrared (FTIR) spectra, alpha-bisabolol incorpora-
tion efficiency and release kinetics were analyzed. 
 
alpha-(-)-bisabolol alpha-(-)-bisabolol  alpha-(+)-bisabolol epi-alpha-(+)-bisabolol 
Figure 1: Chemical structure of the four diastereoisomers of alpha-bisabolol. The alpha-(-)-
bisabolol is the most common form (adapted from Kamatou and Viljoen, 2010). 
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MATERIALS AND METHODS 
 
Materials 
 
Membranes were produced using chitosan from 
shrimp shells (Sigma-Aldrich, C3646, lot number 
061M0046V, with a degree of deacetylation of 
88%), guar gum (Sigma-Aldrich, G4129, lot number 
087K0128), polycaprolactone (Sigma-Aldrich, 440744, 
lot number MKBJ4388V, with average molar mass 
of 80 kDa and polydispersity index 1.7), glacial ace-
tic acid, ethanol and chloroform (Synth). Alpha-
bisabolol, Albi®, with purity of 96%, was kindly do-
nated by the company Atina (Ativos Naturais). The 
water used in the tests was distilled and deionized in 
the Milli-Q® system (Millipore). 
 
Methods 
 
Membranes Preparation and Alpha-Bisabolol In-
corporation 
 
Ch-G membranes were prepared according to ad-
aptations of the procedures described by Haupt et al. 
(2006). Solutions of chitosan (aqueous acid solution 
2% v/v) and guar gum (aqueous solution) at a con-
centration of 0.5% (w/v) were used. The volume of 
each solution was 90 mL and chitosan solution was 
added at a flow rate of 300 mL/h by the use of a 
peristaltic pump (Minipuls 3, Gilson) to guar gum 
solution in a stainless steel jacketed vessel with an 
internal diameter of 10 cm and a height of 20 cm. 
The temperature was maintained throughout the 
process at 25 °C by using a thermostatic bath (214 
M2 Quimis). During the addition of the chitosan so-
lution, the system was kept under constant stirring 
speed of 1000 rpm with the aid of a mechanical 
stirrer (251 D Quimis) coupled to a marine propeller 
with 2.5 cm radius. After the addition of chitosan to 
the guar gum solution was completed, the polymer 
mixture was deaerated with a vacuum pump (Q-
355B2, Quimis) during 120 minutes, transferred to a 
polystyrene Petri dish of 15 cm diameter and the sol-
vent was evaporated in an oven with air circulation 
(410D, New Ethics) for 24 hours at 37 °C. The mem-
brane was then washed for 1 minute with 100 mL of 
1M NaOH solution 1:1 v/v (water: ethanol) to 
neutralize the residual acetic acid and then with 
water (200 mL twice for 30 minutes). Final drying 
was performed for 24 hours at room temperature. 
For the preparation of PCL membranes, polymer 
pellets were dissolved in 20 mL of chloroform at a 
concentration of 2% (w/v) under magnetic stirring 
(Big Squid IKA). The mixture was then deaerated for 
10 minutes in a sonicator (3510R-DTH, Bransonic) 
and transferred to a glass Petri dish of 9 cm diameter. 
The Petri dish was left at room temperature on a 
rotatory plate inside a fume hood for 24 hours for 
complete evaporation of the solvent. 
Incorporation of alpha-bisabolol was done by di-
rect addition (DA) of the compound into PCL solu-
tion at the proportion of 0.2:1 (w/w) of alpha-bisabolol 
to polysaccharides. This ratio was chosen to avoid 
undesired interference on the formation of the poly-
meric matrix. For Ch-G membranes, alpha-bisabolol 
was incorporated during membrane swelling result-
ing from the absorption (AS) of ethanol or hydroeth-
anolic solution (25:75 v/v of water/ethanol) at con-
centrations varying from 0.075 to 7.5 mg/mL. Sam-
ples of 1 cm × 1 cm dimensions previously stored in 
a desiccator with 22% of moisture content were 
incubated in the presence of 4 mL of the solution 
containing the active compound for one hour under 
mixing at 100 rpm and 25 °C. 
 
Membranes Characterization 
 
Membrane characterization was performed based 
on procedures described by Bueno and Moraes 
(2011) and Veiga and Moraes (2011), unless other-
wise stated. 
 
Morphology 
 
The morphology of 2 cm x 1 cm samples was 
evaluated using a scanning electron microscope 
(LEO 440i, Leica). Samples previously stored in a 
desiccator for 24 h were fixed on adequate stubs and 
metalized (mini Sputter coater, SC 7620) by deposit-
ing a thin layer of gold (92 Å). For the evaluation of 
cross section, samples were cryofractured with liquid 
nitrogen. 
 
Color and Opacity 
 
Color and opacity of the membranes were deter-
mined with a colorimeter (ColorQuest II, Hunterlab) 
operating in the transmittance mode, using the 
CIELab patterns and the Hunterlab method (Hunter 
Associates Laboratory, 1997). Hue and Chroma pa-
rameters were calculated using Equations (1) and (2), 
respectively: 
 
*1
*( )bHue tan a
             (1) 
 
    0,52 2* *Chroma a b              (2) 
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where a* and b* are the color parameters provided by 
the equipment. The color of the sample was given by 
the orientation of Hue angle in the CIELab diagram 
(Voss, 1992). 
Opacity (Y) of the membranes, in percentage, was 
calculated by the equipment as a relationship be-
tween the opacity of each sample over a black stand-
ard (Yp) and the opacity of each sample over a white 
standard (Yb), according to Equation (3). 
 
100p
b
Y
Y
Y
    
             (3) 
 
Fourier Transform Infrared (FTIR) Spectroscopy  
 
FTIR was performed in order to identify the func-
tional groups present in the samples and evaluate 
interactions between the polymers in the membranes, 
as well as to detect possible changes in the structure 
of the polymeric matrices after incorporating alpha-
bisabolol. The data were obtained on a spectropho-
tometer (Nicolet 6700, ThermoScientific) operating 
in the attenuated total reflectance (ATR) mode (Smart 
Omni-Sampler accessory) with wavenumbers rang-
ing from 4000 to 675 cm-1, resolution of 4 cm-1 and 
32 accumulated scans for reading membrane sam-
ples. For powder samples, KBr pellets were used and 
the range of wavenumbers was adjusted to 4000 to 
400 cm-1. 
 
Uptake Capacity and Stability in Ethanol and Hy-
droethanolic Solution 
 
Uptake capacity of ethanol or hydroethanolic so-
lution (25:75 v/v water/ethanol) was determined 
using 6 cm x 1 cm membrane samples, in triplicate, 
with initial mass (Mi) previously determined after 
storage in a desiccator for 24 hours. Samples were 
exposed to 10 mL of the tested solution for 1 hour at 
25 °C. After this period, the excess of solution was 
removed with filter paper and samples were weighed 
(Mf). The uptake capacity of ethanol and hydroeth-
anolic solution, in gsolution/gmembrane, was calculated 
using Equation (4). 
 
 f i
i
M M
U
M
               (4) 
 
To determine the stability of the material exposed 
to the mentioned solutions, each sample was im-
mersed for 5 minutes in 20 mL of water for 5 times 
to remove weakly bonded compounds such as salts 
and polysaccharides. After that, the sample was dried 
in an incubator for 24 h at 37 °C, kept in a desiccator 
for 24 h and then weighed again (Md). The percentage 
of mass loss (L) was calculated using Equation (5). 
 
100i d
i
M ML
M
              (5) 
 
Alpha-Bisabolol Incorporation Efficiency 
 
Efficiency of alpha-bisabolol incorporated in the 
Ch-G membranes by the AS method was determined 
via quantification of the compound remaining in the 
ethanol or hydroethanolic solution after the end of the 
incubation period by spectrophotometry at 208 nm. 
The same procedure was performed with membranes 
immersed in solutions without alpha-bisabolol, in 
order to quantify solvent extractable compounds that 
were not the test compound and could possibly 
interfere in absorbance measurements.  
The mass of alpha-bisabolol retained in the sam-
ple (Mc,f) was determined by calculating the differ-
ence between the mass of compound initially added 
to the film (Mc,i) and the mass remaining in the solu-
tion. The incorporation efficiency (ε), in percentage, 
was then calculated using Equation (6). 
 
,
,
100C f
C i
M
M
                (6) 
 
For PCL membranes, the incorporation efficiency 
by the DA method was also calculated according to 
Equation (6). Neither evaporation of bioactive 
compound nor its retention in the Petri dish were 
observed. 
 
Alpha-Bisabolol Release Kinetics 
 
Alpha-bisabolol release kinetics were evaluated 
using Ch-G and PCL membrane samples of dimen-
sions equal to 1 cm x 1 cm in triplicate with different 
alpha-bisabolol/polymer mass ratios.  
Samples with initial alpha-bisabolol/polymer mass 
ratios around 0.2 were weighed and placed in nylon 
supports at the top of quartz cuvettes containing 3 
mL PBS buffer, under mixing at 100 rpm and 37 °C. 
Preliminary tests were performed to determine the 
upper limit of alpha-bisabolol concentration in PBS, 
defined by the concentration above which no altera-
tion was detected in the absorbance of the release 
solution. To avoid saturation of the PBS solution 
with alpha-bisabolol, the release medium was re-
placed at predetermined periods. For the Ch-G mem-
branes with higher alpha-bisabolol/polymer mass ra-
tios, the test was carried out in flasks containing 10 mL 
of PBS to prevent rapid saturation of the release 
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medium. Cuvettes and flasks were sealed with para-
film and the incubator environment was saturated 
with water to minimize loss of the release medium 
by evaporation. Periodically, the medium was ana-
lyzed for alpha-bisabolol concentration by spectro-
photometry at 208 nm. For the experiments per-
formed using 3 mL of release medium, the absorb-
ance values were determined by direct measurement 
in the cuvettes. For Ch-G membranes exposed to 
10 mL of PBS, 1 mL aliquots were taken from the 
bulk solution and, after absorbance measurements, 
returned to the flasks. 
 
 
RESULTS AND DISCUSSION 
 
Alpha-Bisabolol Incorporation 
 
Before alpha-bisabolol incorporation, Ch-G and 
PCL membranes were exposed to ethanol and to a 
25:75 v/v water/ethanol solution to determine their 
uptake capacity and stability in these solvents. The 
results of these tests, indicated in Table 1, were im-
portant for the choice of the most appropriate 
incorporation method to be used for each type of 
membrane. PCL samples had a very low uptake 
capacity of both solutions; therefore, the swelling 
required for penetration of alpha-bisabolol present in 
solution and its diffusion through the matrix would 
not occur. For this reason, the DA method was 
chosen as the most suitable for incorporating the 
active compound into PCL membranes, since this 
approach eliminates the need of matrix swelling for 
penetration of the compound. 
 
Table 1: Uptake capacity (U) and mass loss (L) in 
ethanol and water/ethanol solution (25:75 v/v) for 
membranes exposed to these solvents for one 
hour. 
 
Sample Solution U (gsolution/gmembrane) L (%)
Ch-G ethanol 0.35 ± 0.09
a 5.26 ± 0.20a
water/ethanol 1.60 ± 0.02b 7.97 ± 0.41b
PCL ethanol 0.07 ± 0.02
c 2.46 ± 0.27c
water/ethanol 0.09 ± 0.01c 2.79 ± 0.31c
Same letter in the same column indicates no significant difference 
between the mean values (Tukey test, p <0.05). 
 
Ch-G membranes showed higher uptake capacity 
of the tested solutions than PCL, and the uptake of 
the hydroethanolic solution was significantly higher 
than that observed for ethanol. The swelling of the 
matrix structure in the hydroethanolic solution was 
probably promoted by the presence of water mole-
cules, which enabled the separation of the polysac-
charide chains, consequently allowing the entry of a 
great amount of the incorporation solution. The in-
corporation of alpha-bisabolol through the AS 
method is more suitable in this case, given that the 
higher degree of swelling observed in these matrices 
would allow enhanced penetration of the active 
compound. If alpha-bisabolol incorporation into Ch-
G membranes by direct addition was employed, its 
limited affinity for the polysaccharide matrix due to 
their different hydrophilicity character would prevent 
effective retention of the active compound in the 
membrane, especially after the washing step. 
Despite the increased uptake of the hydroeth-
anolic solution presented by both types of mem-
branes, mass loss in this solution, as well as in 
ethanol, was not significant, indicating that the two 
formulations are stable in the tested solvents. 
The incorporation of alpha-bisabolol in PCL films 
by the direct addition method at the initial mass ratio 
of 200 mg per gram of polysaccharides resulted in an 
average retention efficiency around 100%. Alpha-
bisabolol losses attributed to carrying during chloro-
form evaporation, to active compound volatilization 
or even to retention on the Petri dish surfaces were 
determined to be negligible. 
Incorporation efficiencies of alpha-bisabolol in 
Ch-G membranes through absorption during swell-
ing are shown in Table 2. For Ch-G samples im-
mersed in ethanol, in all cases, low alpha-bisabolol 
incorporation efficiencies were observed, ranging 
from 7% to 9% for incorporation solutions with 
higher concentration (with no significant statistical 
difference among them) and equal to 0.3% when 
the solution with lower alpha-bisabolol concentra-
tion was used. This result reflects those obtained for 
the uptake of ethanol (Table 1), which showed the 
low capacity of the Ch-G membranes to swell in 
this solvent and, after drying, to retain compounds 
dissolved therein. Despite the low affinity of the 
matrix for the solvent and for the active compound 
itself, the incorporation efficiency obtained by this 
method was still satisfactory regarding final dosage 
requirements. 
When using water as co-solvent in the incorpora-
tion solution, the incorporation efficiency and the 
corresponding amount of compound retained in the 
matrices reached values up to twice greater than 
those observed when using only ethanol (Table 2). 
This result is due to the fact that the samples’ uptake 
of the hydroethanolic solution is significantly higher 
than its uptake of ethanol (Table 1). When using the 
hydroethanolic incorporation solution at a concen-
tration of 1.2 mg/mL of alpha-bisabolol, the amount 
of compound retained in the membrane (224.90 ± 
21.45 mg/g) was equivalent to that obtained for the 
PCL membrane (200 mg/g). 
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Table 2: Incorporation efficiencies of alpha-bisabolol to Ch-G membranes by immersion in ethanol and 
water/ethanol solution (25:75 v/v) (AS method). 
 
Solvent 
Initial concentration of  
alpha-bisabolol  
(mg/mL) 
Alpha-bisabolol added 
(mg/g) 
Alpha-bisabolol retained 
(mg/g) 
Incorporation efficiency 
(%) 
ethanol 
0.075 73.2 0.2 ± 0.1a 0.3 ± 0.1a
1.2 1116.3 96.1 ± 27.7b 9.2 ± 2.7b 
3.0 2857.1 236.6 ± 10.7c 7.3 ± 0.1b 
7.5 7500.0 509.1 ± 28.4d 6.6 ± 0.2b 
water/ethanol 
0.075 74.1 10.3 ± 1.9e 15.1 ± 2.1c 
1.2 1348.3 224.9 ± 21.5c 16.7 ± 1.3c 
3.0 3000.0 537.3 ± 41.9d 18.1 ± 1.5c 
7.5 6122.5 1076.5 ± 22.1f 17.6 ± 1.2c
Same letter in the same column indicates no significant difference between the mean values (Tukey test, p <0.05). 
 
 
Even though the incorporation efficiency of alpha-
bisabolol in the Ch-G membranes by the AS method 
was not high, the advantage of this method is that a 
great amount of the compound may be retained in 
the membranes, varying with the initial concentra-
tion of the incorporation solution used. The remain-
ing solution contains, at the end of the process, a 
large fraction of the alpha-bisabolol initially solubil-
ized therein, but it can still be reused in new incor-
poration batches. This strategy would then increase 
the overall efficiency of the process and the feasibil-
ity of this method. Alternatively, it would also be 
possible to use a technique for the production of 
polymeric nanocapsules or dense nanoparticles con-
taining alpha-bisabolol, following their incorporation 
into Ch-G membranes as an attempt to increase the 
incorporation efficiency of the active agent into the 
matrices. However, the approach chosen in the pre-
sent work can be considered to be more attractive 
because it is technically simpler and less costly. 
The PCL membranes incorporating alpha-bisabolol 
by the DA method and the Ch-G samples retaining 
the greatest amount of the bioactive compound ob-
tained when using the AS method, i.e., the for-
mulation prepared with alpha-bisabolol solubilized at 
7.5 mg/mL in the hydroethanolic solution, were fur-
ther characterized as follows. 
 
Visual Aspect and Morphology 
 
The typical appearance of Ch-G membranes in 
which the active compound was incorporated by the 
AS method (Figure 2B) did not change in compari-
son to those in which the compound had not been 
incorporated (Figure 2A), although the amount of 
alpha-bisabolol retained in the first formulation was 
highly significant (ca. 1 g/g). PCL membranes con-
taining alpha-bisabolol obtained by using the DA 
method (Figure 2D) were visually more opaque than 
those in which this compound was not incorporated 
(Figure 2C).  
 
 
 
Figure 2: Visual aspects of Ch-G films without al-
pha-bisabolol (A) and in which the compound was 
incorporated by the AS method with water/ethanol 
solution (25:75 v/v) at a concentration of 7.5 mg/mL 
(B); and PCL films without alpha-bisabolol (C) and 
in which the compound was incorporated by the DA 
method using the proportion of 20% (m/m) (D). 
 
In accordance with the visual analysis results, 
color and opacity parameters of PCL membranes 
without alpha-bisabolol indicate that this formulation 
presents greater opacity than the Ch-G formulation 
also free of the compound (Table 3). Hue values show 
that Ch-G membranes are greenish-yellow while 
PCL membranes are yellowish-green. However, the 
Chroma parameter indicates that the intensity of 
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these colors is very low. The results obtained in this 
work for the color and opacity of Ch-G membranes 
differ from those reported by Rao et al. (2010), who 
obtained chitosan and guar gum membranes with 
lower opacity (15.91 ± 0.52%) and yellowish-green 
color with greater intensity (Hue = -57.76 and 
Chroma = 6.79). This difference may be attributed to 
the different method of preparation of the mem-
branes used by Rao et al. (2010), which did not 
include the neutralization step. In the present work, it 
was precisely at this step that the color of Ch-G 
membranes changed to a noticeably yellowish. The 
existence of the neutralization step in the process of 
membrane production is important because it avoids 
potential dissolution of chitosan in aqueous solutions 
such as body fluids and, moreover, eliminates the 
irritating effect that the membrane could present 
when in contact with the lesion due to residual acetic 
acid. The difference of opacity may be related to the 
fact that the membranes obtained by Rao et al. 
(2010) had a thickness about 2.5 times lower than 
those described in the present study (data not 
shown). Greater film thickness results in higher diffi-
culty of light to pass through it, since the amount of 
material present therein is increased. 
The data in Table 3 also confirm the results re-
garding the visual analysis of PCL samples contain-
ing alpha-bisabolol incorporated by the DA method, 
since the opacity of the material increased after in-
corporation of the compound. This increase may 
have been a result of morphological changes in the 
membrane due to the introduction of the active com-
pound, which made it less uniform and promoted, as 
a consequence, more intense light scattering. These 
changes in membrane morphology are confirmed in 
Figures 3G and 3H. Also, for these membranes, the 
value of Hue angle underwent little change, but the 
color of the samples was not altered when compared 
with that of membranes without the active compound. 
For the Ch-G formulation in which alpha-bisabolol 
was incorporated by the AS method the color and 
opacity parameters were not significantly different 
when compared to those of membranes without the 
compound (Table 3). 
Martins et al. (2012) and Peng and Li (2014) in-
corporated lipophilic natural compounds with anti-
oxidant (alpha-tocopherol) and antimicrobial proper-
ties (essential oils of lemon, cinnamon and thyme) 
into hydrophilic chitosan membranes. In contrast to 
what was observed in the present work for Ch-G 
membranes, these authors observed an increase in 
the opacity of the films after the introduction of the 
active compounds into the matrices. However, the 
incorporation method used by the authors was the 
DA strategy that, when used in the present work for 
introducing alpha-bisabolol into the hydrophobic 
PCL matrix, also resulted in increased opacity of the 
membrane. Peng and Li (2014) attributed the in-
crease in opacity to morphological changes resulting 
from the introduction of the essential oils in the 
membrane structure, while Martins et al. (2012) sug-
gested that alpha-tocopherol addition decreased the 
transparency of chitosan. 
Figures 3A and 3B show that Ch-G samples with-
out alpha-bisabolol have irregular surfaces, but dense 
and continuous structure. For Ch-G membranes in 
which alpha-bisabolol was incorporated by immer-
sion in hydroethanolic solution (Figures 3C and 3D), 
it is possible to observe regions containing structures 
similar to bubbles on their surface in which the com-
pound was probably located. The cross-sectional 
analysis also revealed a dense structure, without visi-
ble pores. 
PCL membranes without alpha-bisabolol (Figures 
3E and 3F) also showed bubbles on their surface, 
similarly to what was reported by Tang et al. (2004), 
who obtained PCL membranes using chloroform as 
solvent. These bubbles may have been generated on 
the film surface during membrane casting, due to the 
rapid evaporation of the solvent, which possibly 
caused the formation of a thin film that hampered the 
diffusion of the remaining chloroform out of the 
matrix, resulting in the accumulation of the solvent 
under the film. The micrographs of the cross section 
reveal the formation of multiple lamellae, which 
corroborates this hypothesis.  
 
Table 3: Color and opacity parameters of membranes without alpha-bisabolol (w/o) and in which alpha-
bisabolol was incorporated by the DA method and by immersion in water/ethanol solution (25:75 v/v) (AS 
method). 
 
Formulation Ch-G PCL 
Incorporation method w/o AS w/o DA 
Alpha-bisabolol concentration 0 7.5 mg/mL 0 20% 
Opacity (%) 24.83 ± 0.49a 24.95 ± 0.78a 75.00 ± 2.17b 81.63 ± 0.32c 
Hue -83.12 ± 0.43a -86.06 ± 0.47a -71.98 ± 0.54b -66.95 ± 0.82c 
Chroma 1.34 ± 0.01a 1.31 ± 0.05a 1.90 ± 0.02b 1.75 ± 0.04c 
Same letter in the same row indicates no significant difference between the mean values (Tukey test, p <0.05). 
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Figure 3: Surface (left) and cross-sectional (right) 
morphology of Ch-G films without alpha-bisabolol 
(A, B), in which the compound was incorporated by 
the AS method with water/ethanol solution (25:75 v/v) 
at a concentration of 7.5 mg/mL of alpha-bisabolol 
(C, D); and PCL films without alpha-bisabolol (E, F) 
and in which the compound was incorporated by the 
DA method using the proportion of 20% (w/w) (G, H). 
 
PCL membranes containing alpha-bisabolol (Fig-
ures 3G and 3H) have interconnected blocks result-
ing from the exclusion of the active compound dur-
ing the formation of the polymeric matrix. Its cross-
sectional image reveals that alpha-bisabolol is driven 
to pockets present within the polymeric matrix, 
where the active compound is probably placed. Yeh 
et al. (2011) produced PCL films with different 
molar masses using acetone as solvent, a compound 
in which the polymer is poorly soluble, and reported 
surface morphology results similar to those obtained 
in this work. Drawing an analogy between the be-
havior observed in both studies, it is possible to as-
sume that the polymer matrix is formed by excluding 
the compound in which its solubility is low, in this 
case alpha-bisabolol, leading to the formation of the 
observed polygonal blocks. 
FTIR Spectra 
 
Comparative FTIR spectra of the polymeric 
membranes, the isolated polymers used in their 
production and alpha-bisabolol are shown in Figures 
4 and 5. 
The spectra of chitosan and guar gum (Figure 4) 
show a band between 3600 and 3000 cm-1, related to 
stretching of hydroxyl groups present in both poly-
mers. Another band is observed between 3000 and 
2800 cm-1 related to axial vibration of C–H bonds. 
Several small peaks characteristic of polysaccharides 
are observed around 1000 cm-1, which are related to 
C–O, C–C, and C–O–C bonds (Smitha et al., 2005; 
Mudgil et al., 2012; Shahid et al., 2013). 
In addition, the chitosan spectrum also shows 
peaks at 1643 cm-1 and 1581 cm-1, related to the C=O 
bond of amide I groups still acetylated and to amino 
groups, respectively (Li et al., 2005; Popa et al., 
2010; Smitha et al., 2005), and a further peak at 
1380 cm-1, attributed to deformation of –CH2 groups 
(Li et al., 2005; Popa et al., 2010; Smitha et al., 
2005). In the guar gum spectra, the peak at 1650 cm-1 
can be related to the bending vibration of –OH groups 
(Wang and Wang, 2009), and the peak at 875 cm-1, 
which is characteristic of this polymer, refers to ga-
lactose and mannose groups (Mudgil et al., 2012; 
Manikoth et al., 2012). 
The Ch-G membrane spectrum (Figure 4) shows 
overlapping of peaks related to chitosan amides and 
guar gum hydroxyls. The resulting peak at 1650cm-1 
has lower intensity, indicating interaction between 
the two polymers. 
 
 
Figure 4: FTIR spectra obtained for Ch-G mem-
branes with or without alpha-bisabolol incorporated 
by the AS method with a solution of water and etha-
nol (25:75 v/v) at a concentration of 7.5 mg/mL. The 
spectra of the isolated components are also shown. 
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Figure 5: FTIR spectra obtained for PCL membranes 
with or without alpha-bisabolol incorporated by the 
DA method. The spectra of the isolated components 
are also shown. 
 
The alpha-bisabolol spectrum (Figures 4 and 5) 
presents regions with characteristic peaks, such as 
the band between 3500 and 3300 cm-1, related to 
stretching of –OH, the peaks between 3000 and 2830 
cm-1, related to axial deformation of C–H bonds and 
the peaks between 1450 and 1370 cm-1, attributed to 
the angular deformations of the C–H bonds (Silva, 
2009). 
The spectrum of the membrane containing alpha-
bisabolol is similar to that of the of the membrane 
without the compound (Figure 4), so it is not possi-
ble to confirm, by this technique, the presence of the 
added compound in the polymer matrix.  
The polycaprolactone pellet spectrum (Figure 5) 
shows peaks at 2948 and 2869 cm-1, related to asym-
metrical and symmetrical stretching of –CH2 groups. 
The intense peak at 1722 cm-1 refers to stretching of 
the carbonyl groups (–C=O), while peaks at 1187 and 
1243 cm-1 are related to vibrations of ester groups. 
The peak at 1295 cm-1 corresponds to stretching of 
C–O and C–C bonds and the peak at1369 cm-1 is 
related to vibrations of –CH2 groups (Khatiwala et 
al., 2008; Suganya et al., 2011; Martínez-Abad et al., 
2013). 
The PCL membrane spectrum did not change 
when compared to that of the polymer in pellet form. 
Similarly, the spectrum of the polymeric membrane 
containing alpha-bisabolol has the same profile as 
that observed for the compound-free membrane 
(Figure 5). This behavior may be attributed to the 
overlapping of alpha-bisabolol and PCL peaks, 
which makes difficult the identification of these 
peaks in the spectrum of the film containing the 
compound. In addition, another explanation would 
be that the observed behavior can indicate no clear 
interaction between the incorporated compound and 
the polymeric matrix. In fact, the micrographs of 
these membranes showed exclusion of alpha-
bisabolol during formation of the matrix (Figures 3G 
and 3H). 
 
Alpha-Bisabolol Release Kinetics  
 
The evaluation of alpha-bisabolol release kinetics 
in a medium that simulates physiological conditions 
(PBS, pH 7.4, at 37 °C) was performed to verify the 
ability of the two types of membrane formulations to 
release the dose of compound required for topical 
use (1 to 10 mg/g). In this part of the study, Ch-G and 
PCL membranes with similar alpha-bisabolol/polymer 
mass ratios were used (225 and 200 mg/g, respec-
tively). For that, the Ch-G formulation containing 
alpha-bisabolol was obtained by exposure to a hy-
droalcoholic solution at a concentration of 1.2 mg/mL 
(AS method), while the PCL membranes were 
prepared as previously described, incorporating the 
compound at an initial mass ratio of 0.2:1 alpha-
bisabolol/PCL (AD method). 
Figure 6 shows alpha-bisabolol release kinetics 
from the PCL membranes. The release medium was 
changed at 15 and 48 hours. A two-stage release pro-
file was observed: relatively faster release occurred 
until 15 hours, followed by a slow release stage. 
Alpha-bisabolol deposited on the surface of the 
membrane and weakly associated to the matrix was 
probably released during the first stage, while the 
fraction of the compound located in the inner layers 
of the membrane, or in the pockets (as seen in 
Figures 3G and 3H) was released in a slow manner 
due to diffusion through the matrix. In addition to the 
limitations imposed by the diffusion process during 
the slow release period, alpha-bisabolol partitioning 
between the hydrophobic membrane and the hydro-
philic release medium should be also considered. 
Due to its hydrophobic character, alpha-bisabolol 
tends to accumulate preferentially in the membrane 
and therefore its release to the medium occurs gradu-
ally and slowly. At 120 hours, a total of about 6% of 
the compound, equivalent to 12 mg/gmembrane, was 
released. 
Figure 7 shows alpha-bisabolol release kinetics 
from the Ch-G membranes. In this case, the release 
medium had to be changed with higher frequency in 
the beginning of the study to avoid its saturation with 
free alpha-bisabolol, at 1, 2, 5 and 48 hours. A re-
lease profile similar to that of alpha-bisabolol incor-
porated in PCL membranes was observed, with a 
faster release period occurring until 15 hours. Proba-
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bly, in a way similar to what was observed for PCL 
membranes, initially the fraction of alpha-bisabolol 
deposited on the surface of Ch-G membranes was 
more rapidly released. Also, in this case, the mem-
branes swell in the presence of PBS, what contrib-
utes to the burst release kinetic behavior noted. 
 
 
Figure 6: Release of alpha-bisabolol incorporated 
into PCL membranes by the DA method in terms of 
mass of compound per mass of membrane ( ) 
and release percentage ( ). The arrows indicate 
the moments in which the release medium was 
changed. 
 
 
Figure 7: Release of alpha-bisabolol incorporated 
into Ch-G membranes by the AS method with the 
compound dissolved at 1.2 mg/mL in hydroethanolic 
solution. Data are shown in terms of mass of com-
pound per mass of membrane ( ) and release per-
centage ( ). The arrows indicate the moments in 
which the release medium was changed. 
 
While the PCL matrix has high affinity for alpha-
bisabolol, the hydrophilic Ch-G membrane presents 
only a limited tendency to interact with it, potentially 
through weak hydrophobic groups such as –CH2 and 
–CH3. However, given that the release medium is 
very hydrophilic, alpha-bisabolol partitioning between 
the hydrated Ch-G membrane and the aqueous phase 
is likely to occur to a certain degree, resulting in a 
significant tendency of the compound to remain 
embedded in the membrane. Since the interaction of 
the compound with the Ch-G membrane would not 
be as intense as that observed for the hydrophobic 
PCL membrane, higher release of alpha-bisabolol 
from Ch-G membranes would be expected, as effec-
tively noticed, reaching a cumulative release fraction 
of 24%, equivalent to 55 mg/gmembrane in 120 hours. 
Figure 8 shows release kinetic data of Ch-G mem-
branes in which alpha-bisabolol was incorporated by 
the AS method using hydroethanolic solution at a 
concentration of the bioactive compound equal to 7.5 
mg/mL. The release medium was changed every 1 
hour until 4 hours. The rapid alpha-bisabolol release 
step occurred within the first 10 hours, and around 
30% of the compound, equivalent to 300 mg/gmembrane, 
was released in 48 hours. The maximum percentage 
of alpha-bisabolol released was very similar for both 
types of Ch-G membranes, as well as their release 
profile with time. Nevertheless, in this case, the cu-
mulative amount of active compound released was 
about 5.5 times greater than that determined for Ch-G 
samples containing less alpha-bisabolol. 
 
 
Figure 8: Release of alpha-bisabolol incorporated 
into Ch-G membranes by the AS method with the 
compound dissolved at 7.5 mg/mL in hydroethanolic 
solution. Data are shown in terms of mass of com-
pound per mass of membrane ( ) and release 
percentage ( ). The arrows indicate the moments 
in which the release medium was changed. 
 
According to Madhavan (1999), who summarized 
several data from the literature regarding the safety 
assessment of alpha-bisabolol, its acute oral values 
of LD50 (dose likely to cause death to 50% of a 
standard population) are 15.1 mL/kg in mice, and 
14.9 and 15.6 mL/kg in male and female rats, respec-
tively, exceeding 5000 mg/kg (Tisserand and Young, 
2014) to rats, and not being teratogenic to rats. Also 
according to Madhavan (1999), alpha-bisabolol was 
negative in a dermal photosensitization study with 
guinea pigs and, in addition, a 28-day dermal toxicity 
 
 
 
 
464                      F. C. B. de Souza, R. F. B. de Souza and Â. M. Moraes 
 
 
Brazilian Journal of Chemical Engineering 
 
 
 
 
study performed through the application of a solution 
containing 4% of alpha-bisabolol with 87.5% purity 
on rats showed that the no-observable-adverse-effect 
level (NOAEL) was equal to 200 mg/kg/day. More 
recent data show that alpha-bisabolol is not irritant to 
rabbits when topically administered at 1% over an 
area of one square inch (Maurya et al., 2014).  
Based on the evidence described above, and on 
the values of the ratio between the mass of the mem-
branes per area (around 6 and 5 mg/cm2 for PCL and 
Ch-G membranes, respectively), it is possible to 
assume that even the cumulative dose of 300 mgalpha-
bisabolol/gmembrane administered through the skin would 
be safe to treat skin lesions. However, potentially the 
local concentration of alpha-bisabolol at the wound 
site would be lower due to removal by blood circula-
tion and alpha-bisabolol permeation in the tissue 
surrounding the lesion. Besides that, swelling of Ch-
G membranes might lead to a decrease in the ratio of 
alpha-bisabolol released per gram of membrane. Ch-G 
membranes can absorb approximately 100% of their 
dry weights when immersed in PBS medium for 24 
hours (data not shown). Since the degree of swelling 
may vary with time, variations in the ratio of alpha-
bisabolol released per gram of membrane would be 
expected. 
Regarding the burst release observed for all 
formulations, this effect may have either negative or 
positive consequences (Huang and Brazel, 2001). 
High drug concentrations made available quickly 
from controlled release devices are generally not 
often desired and may be associated with local or 
systemic toxicity. However, the burst behavior may 
be interesting for certain applications in which rapid 
release or high initial rates of delivery are required. 
Skin wound treatment is an example of this applica-
tion type, as an initial burst of the active agent, 
below the toxic concentration, would provide imme-
diate relief to the patient followed by prolonged 
release to promote gradual healing. Thus, in the 
present work, it is reasonable to assume that the burst 
release would probably be an attractive characteristic 
of the developed systems, since the cumulative dose 
of alpha-bisabolol released was considered safe for 
wound treatment applications. It should be pointed 
out, though, that even if burst release is desirable, it 
cannot be controlled (Huang and Brazel, 2001). 
Thereby, alternatives to avoid this behavior could be 
used, such as the encapsulation of the active com-
pound in slow release particles followed by their 
incorporation into the membranes, as well as mem-
brane surface coating with another polymer, which 
would increase the resistance to diffusion (Allison, 
2008). Moreover, in a practical application, the 
previous surface extraction method could be used. 
This method comprises the extraction of the drug for 
a short period of time in vitro, by immerging the 
dressing in appropriate release media, before using it 
in an in vivo application (Huang and Brazel, 2001). 
 
 
CONCLUSIONS 
 
Alpha-bisabolol incorporation into PCL mem-
branes made them more opaque, but did not change 
the Ch-G membranes visual aspect. Thus, regarding 
this property, the last formulation would be more 
appropriate as a wound dressing since it is more 
translucent and allows better visual monitoring of the 
wound site. 
For both formulations, alpha-bisabolol release 
showed an initial burst followed by a long slow 
release period. A greater amount of alpha-bisabolol 
was released from Ch-G when compared to PCL 
membranes. Both formulations were able to release 
the dosage of the compound commonly used in topi-
cal formulations (1 to 10 mg/gvehicle), and the final 
cumulative doses reached up to 300 mg of alpha-
bisabolol per gram of dry membrane. Even though 
the amount of alpha-bisabolol released was higher 
than the common topical dose, the use of this com-
pound for the treatment of skin lesions may be 
considered to be safe.  
The slow release may be advantageous since the 
dressings obtained could be used as reservoirs of the 
active compound for long periods, requiring less 
frequent changes and thus providing more comfort to 
the patient. Because a significant fraction of alpha-
bisabolol remains in the matrices and since the active 
compound has antimicrobial activity, the membranes 
could also act as barriers against the penetration of 
microorganisms to open lesions. 
When released to the wound site, alpha-bisabolol, 
which is also an antioxidant and anti-inflammatory 
agent, would reduce the incidence of infection and 
inflammation. Considering the overall results, the 
use of Ch-G membranes would be more appropriate 
for lesions in the early stages of recovery, while PCL 
membranes would be suitable for the treatment of 
lesions in late stages of healing, since the occurrence 
of infections and inflammations in this last condition 
is reduced. Furthermore, late stage healing wounds 
are generally low exuding, which also makes the 
application of PCL membranes more appropriate in 
this case, as they are hydrophobic and thus cannot 
absorb large amounts of exudate. 
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